Author's posts
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
So-called “value-based care” is a field ripe for startups, especially ones utilizing telemedicine and medical specialists who aren’t doctors, like nurses and nutritionists.
With Launch Of New CRISPR Company, Competition Extends To Diagnostics
One of Sherlock Biosciences’ key technologies comes from the Broad Institute lab of Feng Zhang, who did some of the early work elucidating the DNA-modifying potential of CRISPR and its associated enzymes after their discovery in bacteria.
Even Before The Elizabeth Holmes Film Hit HBO, Theranos Cast A Long Shadow On Healthcare Startups
On Monday, a documentary on Elizabeth Holmes and her fraudulent blood-testing company Theranos will air on HBO. The story has already become a reference point for startups trying to hack healthcare.
After Selling Her Genetic Data Mining Software Company, A 32-Year-Old CEO Relaunches It With A Microsoft Partnership
Country-scale genome sequencing projects are producing “the largest datasets on the planet,” Spiral Genetics CEO Adina Mangubat says. Spiral’s goal is to make sense of them.
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression
The green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades…
New York Biotech Raises $61 Million To Keep Cancer Cells Dormant, Bucking Conventional Treatments
Cancer is thought of as a disease of uncontrolled growth. But over the past few decades scientists have been learning more about cancer cells that behave in a very uncancerlike way.
Alphabet’s Verily Launches Opioid Treatment Nonprofit In Ohio
The new venture, called OneFifteen, is a Dayton, Ohio-based nonprofit that will provide residential as well as outpatient addiction care, recovery housing and wraparound services like vocational training, regardless of patients’ insurance coverage.
After Theranos, Healthcare Startups Still Aren’t Publishing Enough Peer-Reviewed Research, Says One Stanford Professor. Venture Capitalists Disagree.
Without published research, scientists and prospective investors and customers have little to go on to evaluate a startup’s marketing claims, the Stanford team maintains.
Data Pirates: Patients And Scientist Battle To Liberate Genetic Testing Results
A small band of patients and a scientist tried to free their existing genetic testing data for cancer research. It was harder than they expected.
Billionaire Doctor Patrick Soon-Shiong Shares New Details On His Latest Cancer-Fighting Company—And How It’s Tied To His Other Firms
The dream for a new cancer treatment is big, but Soon-Shiong’s public companies have not fared well in the markets beyond their initial IPOs.
